Related references
Note: Only part of the references are listed.Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy
Masanori Someya et al.
MEDICAL MOLECULAR MORPHOLOGY (2021)
Analysis of radiotherapy-induced alteration of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma
Yasumasa Mori et al.
ONCOLOGY LETTERS (2021)
Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy
Takaaki Tsuchiya et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy
Masanori Someya et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer
Hong Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2020)
Cervical cancer patients that respond to chemoradiation therapy display an intense tumor infiltrating immune profile before treatment
Patrícia Rocha Martins et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma
Yuki Fukushima et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Radiation effects on antitumor immune responses: current perspectives and challenges
Thomas Walle et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Developments in L2-based human papillomavirus (HPV) vaccines
Christina Schellenbacher et al.
VIRUS RESEARCH (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
Panagiotis Balermpas et al.
ONCOIMMUNOLOGY (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Tumor-intrinsic oncogene pathways mediating immune avoidance
Stefani Spranger et al.
ONCOIMMUNOLOGY (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Sung-Jong Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Weijie Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
Michael Spiotto et al.
SCIENCE IMMUNOLOGY (2016)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The interplay between HPV and host immunity in head and neck squamous cell carcinoma
Anne Skou Andersen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Are 20 human papillomavirus types causing cervical cancer?
Marc Arbyn et al.
JOURNAL OF PATHOLOGY (2014)
The human papillomavirus family and its role in carcinogenesis
Massimo Tommasino
SEMINARS IN CANCER BIOLOGY (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Human papillomaviruses and cancer
Juliane Haedicke et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
Updating the Natural History of Human Papillomavirus and Anogenital Cancers
Anna-Barbara Moscicki et al.
VACCINE (2012)
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix
Walayat Shah et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Gene Signature in Melanoma Associated With Clinical Activity A Potential Clue to Unlock Cancer Immunotherapy
Thomas F. Gajewski et al.
CANCER JOURNAL (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence
Paolo Bonanni et al.
VACCINE (2009)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance
MY Mapara et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles
T Storni et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
